SEC Form 4 · accession 0001209191-15-076587
LEMAITRE VASCULAR INC · LMAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael T Wijas
Officer — VP of Sales, The Americas
Period of report
Oct 22, 2015
Accepted (ET)
Oct 23, 2015 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001158895
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $12.76 | Oct 22, 2015 | A | 11,730 | A | Oct 22, 2015 | Oct 22, 2022 | Common Stock | 11,730 | 11,730 | D |
Explanation of responses
- F1This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.